antirheumatic


Also found in: Dictionary.

antirheumatic

 [an″te-, an″ti-roo-mat´ik]
counteracting rheumatism and rheumatoid disease.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

an·ti·rheu·mat·ic

(an'tē-rū-mat'ik), Although the digraph rh occurring at the beginning of a syllable in a word of Greek origin is ordinarily changed to rrh when a prefix or other lexical element is placed before it, the r is not doubled in this word.
1. Denoting an agent that suppresses manifestations of rheumatic disease; usually applied to antiinflammatory agents or agents that are capable of delaying progression of the basic disease process in inflammatory arthritis.
2. An agent possessing such properties (for example, gold compounds).
Farlex Partner Medical Dictionary © Farlex 2012

antirheumatic

Any treatment for, or prophylaxis against, any form of rheumatism.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
Mentioned in ?
References in periodicals archive ?
The efficacy and safety of Taltz in AS was demonstrated in two randomized, double-blind, placebo-controlled Phase 3 studies that included 657 adult patients with active AS: COAST-V in patients who are biologic disease-modifying antirheumatic drug (bDMARD)-naive and COAST-W in patients who previously had an inadequate response or were intolerant to tumor necrosis factor (TNF) inhibitors.
Lilly Receives U.S. FDA Approval for Taltz for the Treatment of Active Ankylosing Spondylitis
Among the 25 transplanted patients, none died during the extended follow-up, 2 experienced cardiac failure, and 23 remained off of any disease-modifying antirheumatic drugs.
Transplant for severe disease shows 11-year benefits
Methotrexate is the first-line disease-modifying antirheumatic drug used in patients with RA (Annals of the Rheumatic Diseases, September 2017).
BONES & JOINTS NEWSBRIEFS
In the last decade, there have been significant advances in the treatment of RA, especially for patients whose arthritis does not respond to conventional disease-modifying antirheumatic drugs (DMARDs).
Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010
According to the company, the SPIRIT-P1 study evaluated the safety and efficacy of Taltz compared to placebo in patients with active PsA who had never been treated with a biologic disease-modifying antirheumatic drug.
Lilly wins US FDA approval for Taltz (ixekizumab) for the treatment of active psoriatic arthritis
The findings are encouraging because patients with rheumatoid arthritis have a higher risk of developing shingles than other adults, and tofacitinib and certain other disease-modifying antirheumatic drugs are thought to further increase this risk.
Here's how to use shingles vaccine in arthritis sufferers
Most participants in the study had longstanding RA and were taking disease-modifying antirheumatic drugs.
Eating fish frequently helps rheumatoid arthritis
A human monoclonal antibody, Kevzara is indicated for use in patients who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (MTX).
Sanofi, Regeneron cleared to market Kevzara
The average duration of RA among all participants was 17 years, and 58 percent of the participants were taking a disease-modifying antirheumatic drug, such as methotrexate, sulfasalazine (Azulfidine), and hydroxychloroquine (Plaquenil).
Some RA patients report a link between diet and symptoms
Researchers compared the health records of more than 11,000 RA patients taking TNFis with the records of about 3,000 RA patients taking synthetic disease-modifying antirheumatic drugs (sDMARDs), another common RA treatment.
Taking TNFis may help lower heart attack risk in people with rheumatoid arthritis
In this comprehensive review of 3,742 relevant publications, there was general agreement that initial treatment should center on disease-modifying antirheumatic drugs (DMARDs) plus systemic glucocorticoids.
All systemic steroid guidelines for RA offer little guidance
Editor's Note: The authors remark that MK-7 is significantly less toxic than antirheumatic drugs and it has the additional benefit of protecting against osteoporosis.
Vitamin K2 shows promise as rheumatoid arthritis treatment

Medical browser ?
Full browser ?